Abdulkarim B, Sabri S, Deutsch E, Chagraoui H, Maggiorella L, Thierry J, Eschwege F, Vainchenker W, Chouaïb S, Bourhis J (2002) Antiviral agent cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene 21:2334–2346. doi:10.1038/sj.onc.1206402
Article
Google Scholar
Ault KA (2006) Clinical study, epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol 40470. doi:10.1155/IDOG/2006/40470
Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP (2006) Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLOS Med 3:0624–0632. doi:10.1371/journal.pmed.0030138
Article
Google Scholar
Bonhoeffer S, May RM, Shaw GM, Nowak MA (1997) Virus dynamics and drug therapy. Proc Natl Acad Sci 94:6971–6976
Article
Google Scholar
Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796–802. doi:10.1093/jnci/87.11.796
Article
Google Scholar
Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265
Article
Google Scholar
Brown V, White KA (2010) The HPV vaccination strategy: could male vaccination have an impact? Comput Math Methods Med 11:223–237. doi:10.1080/17486700903486613
Article
MathSciNet
MATH
Google Scholar
Brown VI, White KAJ (2011) The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study. Math Biosci 231:126–134. doi:10.1016/j.mbs.2011.02.009
Article
MathSciNet
MATH
Google Scholar
Clifford GM, Smith JS, Aguado T, Franceschi S (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89:101–105. doi:10.1038/sj.bjc.6601024
Article
Google Scholar
Elbasha EH, Dasbach EJ, Insinga RP (2007) Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 13:28–41. doi:10.3201/eid1301.060438
Article
Google Scholar
Elbasha EH (2008) Global stability of equilibria in a two-sex HPV vaccination model. Bull Math Biol 70:894–909. doi:10.1007/s11538-007-9283-0
Article
MathSciNet
MATH
Google Scholar
Forde J, Nelson P (2004) Application of Sturm sequence to bifurcation analysis of delay differential equation models. J Math Anal Appl 300:273–284. doi:10.1016/j.jmaa.2004.02.063
Article
MathSciNet
MATH
Google Scholar
Globocan 2008 (2010) http://globocan.iarc.fr/, Downloaded March 2012
Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ (2008) Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst 100:308–320. doi:10.1093/jnci/djn019
Article
Google Scholar
Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E (2004) Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96:604–615. doi:10.1093/jnci/djh104
Article
Google Scholar
Hostetler KY, Rought S, Aldern KA, Trahan J, Beadle JR, Corbeil J (2006) Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro. Mol Cancer Ther 5:156–159. doi:10.1158/1535-7163.MCT-05-0200
Article
Google Scholar
IARC (2005) IARC handbooks of cancer prevention, cervix cancer screening. IARC Press, Lyon
IARC (2007) IARC monographs on the evaluation of carcinogenic risk to humans, volume 90, human papillomavirus. IARC Press, Lyon
Kim JJ, Brisson M, Edmunds WJ, Goldie SJ (2008) Modeling cervical cancer prevention in developed countries. Vaccine 26:K76–K86. doi:10.1016/j.vaccine.2008.06.009
Article
Google Scholar
Kohli M, Ferko N, Martin A, Franco EL, Jenkins D, Gallivan S, Sherlaw-Johnson C, Drummond M (2007) Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer 96:143–150. doi:10.1038/sj.bjc.6603501
Article
Google Scholar
Kulasingam SL, Myers ER (2003) Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 290:781–789. doi:10.1001/jama.290.6.781
Article
Google Scholar
Lee C, Laimins LA (2007) The differentiation-dependent life cycle of human papillomaviruses in keratinocytes. In: Garcea R, Di Maio D (eds) The papillomaviruses. Springer, New York, pp 45–67
Chapter
Google Scholar
Lee SL, Tameru AM (2012) A mathematical model of human papillomavirus (HPV) in the United States and its impact on cervical cancer. J Cancer 3:262–268. doi:10.7150/jca.4161
Article
Google Scholar
Lowy DR, Kirnbauer R, Schiller JT (1994) Genital human papillomavirus infection. Proc Natl Acad Sci USA 91:2436–2440
Article
Google Scholar
Motoyama S, Ladines-Llave CA, Villanueva SL, Maruo T (2004) The role of human papilloma virus in the molecular biology of cervical carcinoma. Kobe J Med Sci 50:9–19
Google Scholar
Mougin C, Dalstein V, Pretet JL, Gay C, Schall JP, Riethmuller D (2001) Epidemiology of cervical papillomavirus infections, recent knowledge. Presse Med 30:1017–1023
Google Scholar
Nowak M, Bangham CRM (1996) Population dynamics of immune responses to persistent viruses. Science 272:74–79
Article
Google Scholar
Nowak M, May R (2000) Virus dynamics, mathematical principles of immunology and virology. Oxford University Press, New York
MATH
Google Scholar
Sanders GD, Taira AV (2003) Cost effectiveness of potential vaccine for human papillomavirus. Emerg Infect Dis 9:37–48. doi:10.3201/eid0901.020168
Article
Google Scholar
Schorge JO, Schaffer JI, Halvorson LM, Hoffman BL, Bradshaw KD, Chunningham FG (2008) Cervical cancer. In: Williams gynecology. McGraw-Hill, NY
Taira AV, Neukersmans CP, Sanders GD (2004) Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 10:915–1923. doi:10.3201/eid1011.040222
Article
Google Scholar
Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine 24:S1/4–S1/15. doi:10.1016/j.vaccine.2005.09.054
Article
Google Scholar
Woodman CBJ, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11–22. doi:10.1038/nrc2050
Article
Google Scholar
Wright TC, Ferenczy A (2002) Anatomy and histology of the cervix. Blaustein’s pathology of the female genital tract, 5th edn. Springer, New York, pp 207–224
Google Scholar